Login to Your Account



CEO tells about Proteostasis IPO bid and counsels on when and how

By Randy Osborne
Staff Writer

Friday, September 16, 2016

BOSTON – Fresh from a follow-on financing round that gave more weight to the unusual IPO carried out in February, Proteostasis Therapeutics Inc. CEO Meenu Chhabra provided a primer of sorts to attendees of Biopharm America.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription